SCHEMBL5790495

SCHEMBL5790495

NC(=O)C1(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.51
CRBN Q96SW2 1/20 0.51
ALDH1A1 P00352 3/20 0.49
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025081 0.92 DDB1 (0.48) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL16661304 0.90 DDB1 (0.56) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL13993260 0.87 SMN1; SMN2 (0.47) DDB1CRBNKMT2ACYP2C19SMN1; SMN2
SCHEMBL1200111 0.86 DDB1 (0.54) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL3615694 0.83 ALDH1A1 (0.58) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL18493339 0.83 DDB1 (0.54) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL25317301 0.82 ALDH1A1 (0.51) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL7228727 0.81 DDB1 (0.52) DDB1CRBNALDH1A1MAPK1L3MBTL1
SCHEMBL15105826 0.81 ALDH1A1 (0.54) DDB1CRBNALDH1A1MAPK1L3MBTL1
Fluoride SCHEMBL27773141 0.81 ALDH1A1 (0.50) DDB1CRBNALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006016237-A2 HETEROCYCLIC DERIVATIVES AS ANTI-INFLAMMATORY AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-02-16 WO claimed
WO-2005016884-A9 CYCLOPROPYL DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS LUNDBECK & CO AS H (DK) 2006-03-16 WO disclosed